Hercules Capital expands Dyne Therapeutics facility to $400m
Hercules Capital has expanded its senior secured term loan facility with Dyne Therapeutics to $400 million. Dyne drew $50 million at this close. It has now borrowed $200 million, with $200 million still available.
2 min read17 Jun 2026